EUVIMEDEUVIMED entdecken
Systematische Übersicht

Effect of Conventional and Ultrahigh Dose Rate FLASH Irradiations on Preclinical Tumor Models: A Systematic Analysis

Till Tobias Böhlen, Jean-François Germond, Kristoffer Petersson, Esat Mahmut Ozsahin, Fernanda G Herrera, Claude Bailat, François Bochud, Jean Bourhis, Raphaël Moeckli, Gabriel Adrian

International Journal of Radiation Oncology*Biology*Physics · 2023-11 · 117 (4) · 1007-1017

DOI: 10.1016/j.ijrobp.2023.05.045 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2023-11. Verfasst von Till Tobias Böhlen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Radiation Physics, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland. Hauptthemen laut MEDLINE: Radiotherapy Dosage. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Cancer Research UK, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Compared with conventional dose rate irradiation (CONV), ultrahigh dose rate irradiation (UHDR) has shown superior normal tissue sparing. However, a clinically relevant widening of the therapeutic window by UHDR, termed "FLASH effect," also depends on the tumor toxicity obtained by UHDR. Based on a combined analysis of published literature, the current study examined the hypothesis of tumor isoefficacy for UHDR versus CONV and aimed to identify potential knowledge gaps to inspire future in vivo studies. METHODS AND MATERIALS: A systematic literature search identified publications assessing in vivo tumor responses comparing UHDR and CONV. Qualitative and quantitative analyses were performed, including combined analyses of tumor growth and survival data. RESULTS: We identified 66 data sets from 15 publications that compared UHDR and CONV for tumor efficacy. The median number of animals per group was 9 (range 3-15) and the median follow-up period was 30.5 days (range 11-230) after the first irradiation. Tumor growth assays were the predominant model used. Combined statistical analyses of tumor growth and survival data are consistent with UHDR isoefficacy compared with CONV. Only 1 study determined tumor-controlling dose (TCD50) and reported statistically nonsignificant differences. CONCLUSIONS: The combined quantitative analyses of tumor responses support the assumption of UHDR isoefficacy compared with CONV. However, the comparisons are primarily based on heterogeneous tumor growth assays with limited numbers of animals and short follow-up, and most studies do not assess long-term tumor control probability. Therefore, the assays may be insensitive in resolving smaller response differences, such as responses of radioresistant tumor subclones. Hence, tumor cure experiments, including additional TCD50 experiments, are needed to confirm the assumption of isoeffectiveness in curative settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Radiotherapy DosageAnimalsMiceNeoplasmsTumor BurdenHumans

Autor:innen und Institutionen

  • Institute of Radiation Physics, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland.
  • Department of Hematology, Oncology, and Radiation Physics, Skåne University Hospital, Lund, Sweden; MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom.
  • Department of Radiation Oncology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland.
  • Institute of Radiation Physics, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland. Electronic address: raphael.moeckli@chuv.ch.
  • Department of Hematology, Oncology, and Radiation Physics, Skåne University Hospital, Lund, Sweden; Division of Oncology and Pathology, Department of Clinical Sciences, Skåne University Hospital, Lund University, Lund,…

Förderung

  • Cancer Research UK
  • Medical Research Council

Zitieren

APA

Böhlen, T. T., Germond, J. F., Petersson, K., Ozsahin, E. M., Herrera, F. G., Bailat, C., Bochud, F., Bourhis, J., Moeckli, R., & Adrian, G. (2023). Effect of Conventional and Ultrahigh Dose Rate FLASH Irradiations on Preclinical Tumor Models: A Systematic Analysis. International Journal of Radiation Oncology*Biology*Physics, 117(4), 1007-1017. https://doi.org/10.1016/j.ijrobp.2023.05.045

Vancouver

Böhlen TT, Germond JF, Petersson K, Ozsahin EM, Herrera FG, Bailat C, et al. Effect of Conventional and Ultrahigh Dose Rate FLASH Irradiations on Preclinical Tumor Models: A Systematic Analysis. International Journal of Radiation Oncology*Biology*Physics. 2023;117(4):1007-1017. doi:10.1016/j.ijrobp.2023.05.045

BibTeX
@article{Bhlen2023,
  author = {Böhlen, Till Tobias and Germond, Jean-François and Petersson, Kristoffer and Ozsahin, Esat Mahmut and Herrera, Fernanda G and Bailat, Claude and Bochud, François and Bourhis, Jean and Moeckli, Raphaël and Adrian, Gabriel},
  title = {Effect of Conventional and Ultrahigh Dose Rate FLASH Irradiations on Preclinical Tumor Models: A Systematic Analysis},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2023},
  volume = {117},
  number = {4},
  pages = {1007--1017},
  doi = {10.1016/j.ijrobp.2023.05.045}
}
Kostenlos starten →